Actively Recruiting
Physician- and Patient-based Barriers to NGS Testing
Led by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins · Updated on 2026-02-03
256
Participants Needed
1
Research Sites
86 weeks
Total Duration
On this page
Sponsors
S
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lead Sponsor
P
Pfizer
Collaborating Sponsor
AI-Summary
What this Trial Is About
The goal of this study is to improve next-generation sequencing (NGS) testing rates at Johns Hopkins in patients with metastatic prostate cancer. Investigators believe by targeting two barriers, provider-level and patient-level, will improve the testing rate of NGS at Johns Hopkins.
CONDITIONS
Official Title
Physician- and Patient-based Barriers to NGS Testing
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Men diagnosed with metastatic prostate cancer
- Seen by Johns Hopkins Medical Oncology as a new patient visit between January 1, 2025 and December 31, 2026
You will not qualify if you...
- Patients who have already had NGS testing performed.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Johns Hopkins Sidney Kimmel Comprehensive Cancer Center
Baltimore, Maryland, United States, 21205
Actively Recruiting
Research Team
C
Catherine Marshall, MD
CONTACT
M
Maddie Klugman
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here